Twist Bioscience Corp — Director's Dealing 2019

Nov 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2019-11-26

Reporting Person: Finn Patrick John (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-26	Common Stock	M	33000	$5.95	Acquired	75596	Direct
2019-11-27	Common Stock	S	36932	$23.3199	Disposed	38664	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-26	Employee Stock Option (right to buy)	$5.95	M	33000	Disposed	2025-09-29	Common Stock (33000)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2: Represents the aggregate of sales effected on the same day at different prices.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.00 to $23.75 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: The option is immediately exercisable. 25% of the shares subject to the option vested on September 01, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.